Bortezomib inhibits the survival and proliferation of bone marrow stromal cells

BACKGROUND: Bortezomib is widely used for the treatment of multiple myeloma. Bone marrow stromal cells (BMSCs) endow myeloma cells with survival and growth advantages. However, the influence of bortezomib on BMSCs is not well elucidated. We examined the effects of bortezomib on the survival and grow...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Res
Autori principali: Kim, Ha-Yon, Moon, Ji-Young, Ryu, Haewon, Choi, Yoon-Seok, Song, Ik-Chan, Lee, Hyo-Jin, Yun, Hwan-Jung, Kim, Samyong, Jo, Deog-Yeon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486164/
https://ncbi.nlm.nih.gov/pubmed/26157778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.2.87
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi